DALLERGY
-
chlorcyclizine hydrochloride and
phenylephrine hydrochloride syrup
Laser Pharmaceuticals, LLC
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Drug Facts
Active ingredients
(in each 5 mL teaspoonful)
Chlorcyclizine
Hydrochloride 12.5 mg
Phenylephrine
Hydrochloride 5 mg
Purpose
Antihistamine
Nasal Decongestant
Uses
temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
- runny nose
- sneezing
- itching of the nose or throat
- itchy, watery eyes
- nasal congestion
- reduces swelling of nasal passages
Warnings
Do not exceed recommended dosage.
Do not use this product
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- difficulty in urination due to an enlargement of the prostate gland
- heart disease
- high blood pressure
- thyroid disease
- diabetes
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product
- excitability may occur, especially in children
- may cause drowsiness
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase the drowsiness effect
- be careful when driving a motor vehicle or operating machinery
Stop use and ask a doctor if
- nervousness, dizziness, or sleeplessness occur
- symptoms do not improve within 7 days or are accompanied by fever
- new symptoms occur
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
Do not exceed 3 doses in a 24 hour period.
Adults and children 12 years of age and over:
| 2 teaspoonfuls (10 mL) every 6 to 8 hours, not to exceed 6 teaspoonfuls in 24 hours
|
Children 6 to under 12 years of age:
| 1 teaspoonful (5 mL) every 6 to 8 hours, not to exceed 3 teaspoonfuls in 24 hours
|
Children 2 to under 6 years of age:
| 1/2 teaspoonful (2.5 mL) every 6 to 8 hours, not to exceed 1 1/2 teaspoonfuls in 24 hours
|
Children under 2 years of age:
| Consult a doctor
|
Other information
Store at 59°-86°F (15°-30°C)
Inactive ingredients
Bitter Mask, Citric Acid, FD&C Blue #1, FD&C Red #40, Glycerin, Grape Flavor, Propylene Glycol, Purified Water, Sodium Citrate, Sorbitol, Sucralose.
Questions? Comments?
Call 1-864-286-8229
LASER
Manufactured for:
Laser Pharmaceuticals, LLC
Greenville, SC 29615
Product Packaging
The packaging below represents the labeling currently used.
Principal display panel and side panel for 473 mL label:
NDC: 16477-820-01
Dallergy®
SYRUP
New Improved Formula
Antihistamine
Nasal Decongestant
Each 5 mL (1 teaspoonful) contains:
Chlorcylizine HCl..............................12.5 mg
Phenylephrine HCl................................5 mg
Patent Pending
Grape Flavor
LASER
16 fl oz (473 mL)
For full prescribing information, see the product foldout.
Store at 59°-86°F (15°-30°C)
Tamper-evident by foil seal under cap. Do not use if foil seal is
broken or missing.
THIS BOTTLE IS NOT TO BE DISPENSED TO THE CONSUMER.
Dispense in a tight, light-resistant container as defined in the
USP/NF with a child-resistant closure.
The labeling for this product includes professional labeling which
is not intended for use by the general public.
WARNING: KEEP THIS AND ALL DRUGS OUT OF REACH OF
CHILDREN. IN CASE OF OVERDOSE, GET MEDICAL HELP OR
CONTACT A POISON CONTROL CENTER RIGHT AWAY.
LASER
Manufactured for:
Laser Pharmaceuticals, LLC
Greenville, SC 29615
Patent Pending
Rev. 08/2011
DALLERGY
chlorcyclizine hydrochloride, phenylephrine hydrochloride syrup |
|
|
|
|
|
Revised: 10/2011 Laser Pharmaceuticals, LLC